BioCentury
ARTICLE | Clinical News

Hybridon preclinical data

September 16, 1996 7:00 AM UTC

Regression of human colon carcinoma in SCID mice was slowed by the agents, prepared by HYBN to target the RI-alpha subunit of cyclic-AMP-dependent protein kinase ( protein kinase A). As reported at th...